Onconetix Profit Margin

Onconetix (ONCO) currently reports a profit margin of -1578.79% as of June 2026. That compares with -3329.72% in the prior-year period — up 52.6% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Onconetix's profit margin history and peer comparisons.

Onconetix's profit margin increased from -3329.72% to -1578.79% — a 52.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Onconetix's profit margin of -1578.79% is lower than the Healthcare sector average of 13.76%. That is roughly 11573.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Onconetix's current -1578.79% should be judged against Healthcare norms (sector average: 13.76%) and against ONCO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1578.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Onconetix, and consider following ONCO for alerts when major investors trade the stock.